Coppell ER

Component Capital Group is a privately held boutique commercial real estate investment company based in Dallas, Texas, that targets unique opportunities in established urban and older first-tier suburban areas. The firm specializes in repositioning core retail real estate assets to create value by adapting to the changing needs of a diverse urban landscape. Leveraging strategic partnerships with FLF Real Estate Management L.P., Component Capital Group provides a comprehensive range of real estate services, including shopping center leasing, property management, and asset management consulting for REO dispositions. The company's focus on the fast-growing Hispanic population allows it to stay ahead of emerging retail concepts and demographic shifts. Generated from the website

Harbert Management Corporation (HMC) is an investment management firm based in Birmingham, Alabama, with a focus on alternative assets and approximately $7.8 billion in regulatory assets under management as of March 31, 2024. Founded in 1993, HMC serves a diverse client base across multiple asset classes, including foundations, endowments, pension funds, financial institutions, and high net worth individuals. As disciplined opportunistic investors, HMC invests alongside its clients on equal terms and conditions, aiming to consistently deliver alpha across the risk spectrum. The firm aspires to be a trusted integrated alternative asset manager that attracts, develops, and retains high-quality talent while maintaining a commitment to excellence in investment strategies and client service. Generated from the website

Endophys Technologies LLC, based in Dallas, TX, is a pioneering company dedicated to revolutionizing hemodynamic data management in medical procedures. Their groundbreaking technology, PressureSense, combines a single-use pressure-sensing sheath with a compact blood pressure monitor, providing real-time and hyper-accurate hemodynamic data without compromising arterial access. With PressureSense, healthcare professionals can make more informed decisions and deliver better patient care, as it offers faster and more reliable intraprocedural blood pressure monitoring, eliminating the need for a radial line and accommodating various internal access devices. Endophys Technologies LLC's mission is to enhance safety and outcomes in critical procedures where time-to-treatment and blood pressure management are paramount. PressureSense, their flagship innovation, represents a significant advancement in hemodynamic data management, marking the first major breakthrough in this field in over 50 years. By capturing real-time data with unparalleled speed and accuracy, PressureSense empowers medical professionals to stay ahead of the curve, providing critical information during diagnostic, interventional, and critical-care procedures, ultimately improving patient outcomes.Generated from the website